Govt opens on-site registration for 18-44 years age for vaccination

The Union government has decided to provide on-site registration / facilitated cohort registration facility on CoWIN digital platform for 18-44 years age group, the Ministry of Health and Family Welfare (MoH&FW) said.

“Considering in case of sessions exclusively organised with online slots, towards the end of the day, some doses may still be left unutilised in case the online appointee beneficiaries do not turn up on the day of vaccination due to any reason.

In such cases, on-site registration of a few beneficiaries may be necessary to minimise the vaccine wastage,” it stated.

It also added, “Even though CoWIN provides for features such as registration of up to four beneficiaries with a mobile number, facilitated registration and appointments through applications, such as ArogyaSetu and Umang, and through the Common Service Centres (CSCs), etc., people requiring facilitated cohort’s facility and those without access to internet or smart phones or mobile phones may still have limited access for vaccination. Therefore, the feature for on-site registration and appointment is now being enabled for 18-44 years age group on CoWIN.”
However, this feature is being enabled only for government C-19 Vaccination Centers (CVCs), at present.

This feature will not be available for private CVCs, at present, and the these will have to publish their vaccination schedules exclusively with slots for online appointments, the ministry said.

It further said, “This feature will be used only upon decision of the respective state government and UT administration to do so. States and UTs must decide on opening of on-site registrations/facilitated cohorts’ registration and appointments for 18-44 years age group based on the local context, just as an additional measure to minimise vaccine wastage and for facilitating vaccination of eligible beneficiaries in the age group 18-44 years.”

The ministry has also advised the states and UTs to issue clear instructions to all district immunisation officers to strictly adhere to the decision of the respective state governments and UT admninstration regarding the extent and manner of using the on-site registration and appointment feature for 18 to 44 years’ age group.

Fully reserved sessions can also be organised for providing vaccination services to the beneficiaries belonging to facilitated cohorts. Wherever such fully reserved sessions are organised, all efforts must also be made to mobilise such beneficiaries in sufficient numbers.

Further, to avoid overcrowding at the vaccination centres, the ministry has advised the states and UTs that abundant caution should be exercised and extreme due care should be taken while opening up of on-site registration and appointment for 18-44 years age group.

Related Posts

  • Pharma
  • April 24, 2024
  • 98 views
India Lifts Safeguard Measures On Isopropyl Alcohol Imports

Mumbai: The Directorate General of Foreign Trade (DGFT) has officially announced the discontinuation of safeguard measures on the import of isopropyl alcohol (IPA). The decision, communicated through Trade Notice dated April…

  • Pharma
  • April 24, 2024
  • 124 views
Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Chandigarh: The Punjab and Haryana High Court today sought response from the Union and State government in PIL seeking implementation of Prevention of Cruelty to Animals Act, 1960 (Resignation of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India Lifts Safeguard Measures On Isopropyl Alcohol Imports

India Lifts Safeguard Measures On Isopropyl Alcohol Imports

Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

AFMS Collaborates With IIT Delhi To Develop Medical Devices

AFMS Collaborates With IIT Delhi To Develop Medical Devices